Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 3/20 | 0.53 |
| ▸ | CPT2 | P23786 | 1/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8439897 | 0.81 | ACLY (0.55) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL4657489 | 0.80 | ACLY (0.53) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL8567208 | 0.77 | CPT2 (0.50) | ACLYCPT2HSPD1BLMHSPE1 | |
| SCHEMBL2870941 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2870981 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2863429 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2872960 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2869644 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2865743 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR | |
| SCHEMBL2864585 | 0.74 | BLM (0.55) | HSPD1BLMHSPE1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11959065-B2 | Bacillus megaterium bioactive compositions and metabolites | PRO FARM GROUP, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-11384332-B2 | Bacillus megaterium bioactive compositions and metabolites | MARRONE BIO INNOVATIONS, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20200267991-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | MARRONE BIO INNOVATIONS, INC. (US) | 2020-08-27 | — | — | US | disclosed |
| US-10602743-B2 | Method of inducing drought/salt tolerance using Bacillus megaterium | MARRONE BIO INNOVATIONS, INC. (US) | 2020-03-31 | — | — | US | disclosed |
| US-9801386-B2 | Bacillus megaterium bioactive compositions and metabolites | MARRONE BIO INNOVATIONS, INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20160113288-A1 | Bacillus Megaterium as Drought/Salt Inducer | PRO FARM GROUP, INC. | 2016-04-28 | — | — | US | disclosed |
| US-20150305346-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | MARRONE BIO INNOVATIONS, INC. | 2015-10-29 | — | — | US | disclosed |
| US-9084428-B2 | Bacillus megaterium bioactive compositions and metabolites | MARRONE BIO INNOVATIONS, INC. (US) | 2015-07-21 | — | — | US | disclosed |
| US-20140051571-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | PRO FARM GROUP, INC. | 2014-02-20 | — | — | US | disclosed |
| US-20110165294-A1 | ABSORBENT PADS FOR FOOD PACKAGING | NOVIPAX INC. | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200267991-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | GZMB, VIP, BAX | ACLY 2675/4885CPT2 1596/4885HSPD1 1366/4885 |
| US-20140051571-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | GZMB, VIP, BAX | ACLY 2675/4885CPT2 1596/4885HSPD1 1366/4885 |
| US-11959065-B2 | Bacillus megaterium bioactive compositions and metabolites | GZMB, VIP, BAX | ACLY 2675/4885CPT2 1596/4885HSPD1 1366/4885 |
| US-20150305346-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | GZMB, VIP, BAX | ACLY 2675/4885CPT2 1596/4885HSPD1 1366/4885 |
| US-11384332-B2 | Bacillus megaterium bioactive compositions and metabolites | GZMB, VIP, BAX | ACLY 2675/4885CPT2 1596/4885HSPD1 1366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.